Literature DB >> 9593713

Identification of the site of inhibition by omeprazole of a alpha-beta fusion protein of the H,K-ATPase using site-directed mutagenesis.

N Lambrecht1, Z Corbett, D Bayle, S J Karlish, G Sachs.   

Abstract

The alpha subunit of eukaryotic P-type ATPases has ten experimentally defined transmembrane or membrane inserted segments. The fifth and sixth of these are short, not predicted by hydropathy analysis, do not insert independently into microsomal membranes, and are readily removed after tryptic digestion and therefore may be membrane inserted sequences. Acid transport by the gastric H, K-ATPase is covalently inhibited by several substituted pyridyl methylsulfinyl benzimidazoles, such as omeprazole. These act as probes of accessible extracytoplasmic thiols because they are accumulated in the acid transporting gastric vesicles and then convert to thiol reactive, cationic tetracyclic sulfenamides. Inhibition is due mainly to disulfide formation with Cys813 or Cys822 in M5/6 and perhaps with a contribution from Cys892 in the loop between transmembrane segment (TM) 7 and TM8. Identification of the specific cysteine responsible for inhibition should be able to define the turn between M5 and M6. The gastric H,K-ATPase alpha-beta heterodimer was expressed as a fusion protein in HEK 293 cells. Transient transfection resulted in most of the protein being retained in the endoplasmic reticulum with only core glycosylation and minor activity of the ATPase evident. Stable transfection resulted in plasma membrane localization of the protein and complex glycosylation. The transfected but not the control cells displayed cation-stimulated, SCH 28080-inhibited ATPase activity and SCH 28080- and omeprazole-inhibited 86Rb uptake. The two cysteines in M5/6 and Cys892 in the TM7/8 loop were mutated to the amino acids found in the Na,K-ATPase in order to determine which of the three cysteine residues were important for benzimidazole inhibition. Mutation of one, two, or all three cysteines did not alter enzyme activity, 86Rb transport, or SCH 28080 inhibition. Only removal of Cys822 blocked omeprazole inhibition of 86Rb transport. These data suggest that Cys822 is present in a region of the enzyme most easily accessed by the cationic sulfenamide formed by omeprazole, presumably the turn between M5 and M6.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9593713     DOI: 10.1074/jbc.273.22.13719

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Na,K-ATPase beta-subunit is required for epithelial polarization, suppression of invasion, and cell motility.

Authors:  S A Rajasekaran; L G Palmer; K Quan; J F Harper; W J Ball; N H Bander; A Peralta Soler; A K Rajasekaran
Journal:  Mol Biol Cell       Date:  2001-02       Impact factor: 4.138

Review 2.  Structural similarities of Na,K-ATPase and SERCA, the Ca(2+)-ATPase of the sarcoplasmic reticulum.

Authors:  K J Sweadner; C Donnet
Journal:  Biochem J       Date:  2001-06-15       Impact factor: 3.857

3.  Janus model of the Na,K-ATPase beta-subunit transmembrane domain: distinct faces mediate alpha/beta assembly and beta-beta homo-oligomerization.

Authors:  Sonali P Barwe; Sanguk Kim; Sigrid A Rajasekaran; James U Bowie; Ayyappan K Rajasekaran
Journal:  J Mol Biol       Date:  2006-10-31       Impact factor: 5.469

4.  ATP4A gene regulatory network for fine-tuning of proton pump and ion channels.

Authors:  Vijai Singh; Indra Mani; Dharmendra Kumar Chaudhary
Journal:  Syst Synth Biol       Date:  2013-01-09

5.  Na,K-ATPase is a target of cigarette smoke and reduced expression predicts poor patient outcome of smokers with lung cancer.

Authors:  Thu P Huynh; Vei Mah; Valerie B Sampson; David Chia; Michael C Fishbein; Steve Horvath; Mohammad Alavi; Debbie C Wu; Jeffrey Harper; Ted Sarafian; Steven M Dubinett; Sigrid A Langhans; Lee Goodglick; Ayyappan K Rajasekaran
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-02-17       Impact factor: 5.464

6.  Omeprazole, a gastric proton pump inhibitor, inhibits melanogenesis by blocking ATP7A trafficking.

Authors:  Mary S Matsui; Michael J Petris; Yoko Niki; Nevena Karaman-Jurukovska; Neelam Muizzuddin; Masamitsu Ichihashi; Daniel B Yarosh
Journal:  J Invest Dermatol       Date:  2014-10-22       Impact factor: 8.551

7.  A Novel Method for Pain Relief in Chronic Pancreatitis: an Old Drug in a New Pack: a Controlled Study.

Authors:  Aswini Kumar Pujahari
Journal:  Indian J Surg       Date:  2016-07-16       Impact factor: 0.656

8.  Nuclear Na+/K+-ATPase plays an active role in nucleoplasmic Ca2+ homeostasis.

Authors:  Charitha Galva; Pablo Artigas; Craig Gatto
Journal:  J Cell Sci       Date:  2012-10-17       Impact factor: 5.285

9.  Regulation of Na,K-ATPase β1-subunit in TGF-β2-mediated epithelial-to-mesenchymal transition in human retinal pigmented epithelial cells.

Authors:  Sridevi Mony; Seung Joon Lee; Jeffrey F Harper; Sonali P Barwe; Sigrid A Langhans
Journal:  Exp Eye Res       Date:  2013-06-28       Impact factor: 3.467

10.  Ebselen, a Small-Molecule Capsid Inhibitor of HIV-1 Replication.

Authors:  Suzie Thenin-Houssier; Ian Mitchelle S de Vera; Laura Pedro-Rosa; Angela Brady; Audrey Richard; Briana Konnick; Silvana Opp; Cindy Buffone; Jakob Fuhrmann; Smitha Kota; Blase Billack; Magdalena Pietka-Ottlik; Timothy Tellinghuisen; Hyeryun Choe; Timothy Spicer; Louis Scampavia; Felipe Diaz-Griffero; Douglas J Kojetin; Susana T Valente
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.